home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Alternative Genetic Cause Of Devastating Dementia

 
  July, 20 2006 7:52
your information resource in human molecular genetics
 
     
Two groups of neuroscientists have uncovered a mutation that can cause frontotemporal dementia (FTD). The discovery may help to resolve confusion over the disease's underpinnings - another mutation is already known to cause the condition, but not all sufferers have this genetic defect, which prompted researchers to look for a secondary cause.

Mutations in a gene called progranulin, which encodes a growth factor, can cause FTD, report research teams led by Christine Van Broeckhoven and Mike Hutton in two papers published online in Nature. The condition, the second most common form of dementia among under-65s, impairs memory, personality and may also affect movement.

Previously, mutations in a neighbouring gene called microtubule-associated protein tau (MAPT; both MAPT and progranulin are situated on the same chromosome) was shown to be associated with some, but not all, cases of FTD. The discovery of another mutation that leads to the disease suggests an alternative mechanism in those patients who do not show MAPT mutations.

Author contacts:

Mike Hutton (Mayo Clinic College of Medicine, Jacksonville, FL, USA)
E-mail: hutton.michael@mayo.edu

Christine Van Broeckhoven (University of Antwerp, Belgium)
E-mail:christine.vanbroeckhoven@ua.ac.be

Articles available online:
Hutton paper.
Van Broeckhoven paper.

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.